View Item 

Show simple item record

The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy

dc.contributor.authorSingleton, J. Robinsonen_US
dc.contributor.authorBixby, Billieen_US
dc.contributor.authorRussell, James W.en_US
dc.contributor.authorFeldman, Eva L.en_US
dc.contributor.authorPeltier, Amandaen_US
dc.contributor.authorGoldstein, Jonathanen_US
dc.contributor.authorHoward, Jamesen_US
dc.contributor.authorSmith, A. Gordonen_US
dc.date.accessioned2010-06-01T19:12:57Z
dc.date.available2010-06-01T19:12:57Z
dc.date.issued2008-09en_US
dc.identifier.citationSingleton, J. Robinson; Bixby, Billie; Russell, James W.; Feldman, Eva L.; Peltier, Amanda; Goldstein, Jonathan; Howard, James; Smith, (2008). "The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy." Journal of the Peripheral Nervous System 13(3): 218-227. <http://hdl.handle.net/2027.42/72400>en_US
dc.identifier.issn1085-9489en_US
dc.identifier.issn1529-8027en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72400
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18844788&dopt=citationen_US
dc.format.extent268451 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights© 2008 Peripheral Nerve Societyen_US
dc.subject.otherDiabetesen_US
dc.subject.otherExamination Scalesen_US
dc.subject.otherPrediabetesen_US
dc.subject.otherSensory Neuropathyen_US
dc.titleThe Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathyen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Neurology, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationotherDepartment of Neurology, University of Utah, Salt Lake City, UTen_US
dc.contributor.affiliationotherDepartment of Neurology, University of Maryland, Baltimore, MDen_US
dc.contributor.affiliationotherDepartment of Neurology, Vanderbilt University, Nashville, TNen_US
dc.contributor.affiliationotherDepartment of Neurology, Yale University, New Haven, CTen_US
dc.contributor.affiliationotherDepartment Pathology, University of Utah, Salt Lake City, UT, USAen_US
dc.identifier.pmid18844788en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72400/1/j.1529-8027.2008.00180.x.pdf
dc.identifier.doi10.1111/j.1529-8027.2008.00180.xen_US
dc.identifier.sourceJournal of the Peripheral Nervous Systemen_US
dc.identifier.citedreferenceAbbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ ( 1998 ). Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 21: 1071 – 1075.en_US
dc.identifier.citedreferenceAmerican Diabetes Association ( 2003 ). American Diabetes Association: report of the expert committee on the diagnosis and classification of diabetes mellitis. Diabetes Care 26: S5 – S20.en_US
dc.identifier.citedreferenceApfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Rendell M, Vinik A, Giuliani M, Stevens JC, Barbano R, Dyck PJ ( 2000 ). Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 284: 2215 – 2221.en_US
dc.identifier.citedreferenceBrown MJ, Bird SJ, Watling S, Kaleta H, Hayes L, Eckert S, Foyt HL ( 2004 ). Natural progression of diabetic peripheral neuropathy in the Zenarestat study population. Diabetes Care 27: 1153 – 1159.en_US
dc.identifier.citedreferenceCohen J, Cohen P ( 1983 ). Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, 2nd Edn. Lawrence Erlbaum Associates, Hillsdale, pp 56.en_US
dc.identifier.citedreferenceCornblath DR, Chaudhry V, Carter K, Lee D, Seysedadr M, Miernicki M, Joh T ( 1999 ). Total neuropathy score: validation and reliability study. Neurology 53: 1660 – 1664.en_US
dc.identifier.citedreferenceDyck JB, Dyck PJ ( 1999 ). Diabetic polyneuropathy. In: Diabetic Neuropathy. Dyck PJ, Thomas PK ( Eds ). W.B. Saunders, Philadelphia, pp 255 – 278.en_US
dc.identifier.citedreferenceDyck PJ, Davies JL, Litchy WJ, O’Brien PC ( 1997 ). Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 49: 229 – 239.en_US
dc.identifier.citedreferenceDyck PJ, O‘Brien PC, Johnson DM, Klein CJ, Dyck JB ( 2005 ). Quantitative sensation testing. In: Peripheral Neuropathy. Dyck PJ, Thomas PK ( Eds ). Elsevier-Saunders, Philadelphia, pp 1063 – 1093.en_US
dc.identifier.citedreferenceFeldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA ( 1994 ). A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17: 1281 – 1289.en_US
dc.identifier.citedreferenceFeldman EL, Stevens MJ, Russell JW, Greene DA ( 1999 ). Diabetic neuropathy. In: Current Review of Diabetes. Taylor S ( Ed ). Current Medicine, Philadelphia, pp 71 – 84.en_US
dc.identifier.citedreferenceGorson KC, Ropper AH ( 1995 ). Idiopathic distal small fiber neuropathy. Acta Neurol Scand 92: 376 – 382.en_US
dc.identifier.citedreferenceGreene DA, Arezzo JC, Brown MB ( 1999 ). Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Neurology 53: 580 – 591.en_US
dc.identifier.citedreferenceHolland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC ( 1998 ). Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 44: 47 – 59.en_US
dc.identifier.citedreferenceThe Italian General Practitioner Study Group ( 1995 ). Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology 45: 1832 – 1836.en_US
dc.identifier.citedreferenceLawson SN ( 2005 ). The peripheral nervous system: Dorsal root ganglion neurons. In: Peripheral Neuropathy. Dyck PJ, Thomas PK ( Eds ). Elsevier-Saunders, Philadelphia, pp 163 – 202.en_US
dc.identifier.citedreferenceLow PA, Mathias CJ. Quantitation of autonomic impairment. In: Peripheral Neuropathy. Dyck PJ, Thomas PK ( Eds ). Elsevier-Saunders, Philadelphia, pp 1103 – 1133.en_US
dc.identifier.citedreferenceLunetta M, Le Moli R, Grasso G, Sangiorgio L ( 1998 ). A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Res Clin Pract 39: 165 – 172.en_US
dc.identifier.citedreferenceMax MB, Lunch SA, Muir J, Shoaf SE, Smoller B, Dubner R ( 1992 ). Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326: 1250 – 1256.en_US
dc.identifier.citedreferenceMcArthur JH ( 1998 ). The reliability and validity of the subjective peripheral neuropathy screen. J Assoc Nurses AIDS Care 9: 84 – 94.en_US
dc.identifier.citedreferenceNotermans NC, Wokke JH, Franssen H, van der Graaf Y, Vermeulen M, van den Berg LH, Bar PR, Jennekens FG ( 1993 ). Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study in 75 patients. J Neurol Neurosurg Psychiatry 56: 1066 – 1071.en_US
dc.identifier.citedreferenceNovella SP, Inzucchi SE, Goldstein JM ( 2001 ). The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 24: 1229 – 1231.en_US
dc.identifier.citedreferencePfeifer MA, Schumer MP ( 1995 ). Clinical trials of diabetic neuropathy: past present and future. Diabetes 44: 1355 – 1361.en_US
dc.identifier.citedreferencePfeifer MA, Schumer MP, Gelber DA ( 1997 ). Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes 46: 82 – 89.en_US
dc.identifier.citedreferenceShy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M ( 2005 ). Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64: 1209 – 1214.en_US
dc.identifier.citedreferenceSingleton JR, Smith AG, Bromberg MB ( 2001a ). Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24: 1448 – 1453.en_US
dc.identifier.citedreferenceSingleton JR, Smith AG, Bromberg MB ( 2001b ). Painful sensory neuropathy associated with impaired glucose tolerance. Muscle Nerve 24: 1225 – 1228.en_US
dc.identifier.citedreferenceSmith AG, Singleton JR ( 2004 ). The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy. Arch Intern Med 164: 1021 – 1025.en_US
dc.identifier.citedreferenceSmith AG, Howard JR, Kroll R, Ramachandran P, Hauer P, Singleton JR, McArthur J ( 2005 ). The reliability of skin biopsy with measurement of intraepidermal nerve fiber density. J Neurol Sci 228: 65 – 69.en_US
dc.identifier.citedreferenceSumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M ( 2003 ). The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60: 108 – 111.en_US
dc.identifier.citedreferenceTesfaye S, Tandan R, Bastyr EJ 3rd, Kles KA, Skljarevski V, Price KL; for the Ruboxistaurin Study Group ( 2007 ). Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials. Diabetes Care 30: 2626 – 2632.en_US
dc.identifier.citedreferenceWolfe GI, Barohn RJ ( 1998 ). Cryptogenic sensory and sensorimotor polyneuropathies. Semin Neurol 18: 105 – 111.en_US
dc.identifier.citedreferenceWolfe GI, Baker NS, Amato AA, Jackson CE, Nations SP, Saperstein DS, Cha CH, Katz JS, Bryan WW, Barohn RJ ( 1999 ). Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol 56: 540 – 547.en_US
dc.identifier.citedreferenceYagihashi S, Yamagishi SI, Wada Ri R, Baba M, Hohman TC, Yabe-Nishimura C, Kokai Y ( 2001 ). Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain 124: 2448 – 2458.en_US
dc.identifier.citedreferenceZiegler D, Nowak H, Kempler P, Vargha P, Low PA ( 2004 ). Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 21: 114 – 121.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1529-8027.2008.00180.x.pdf
Size:
262.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.